Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S.

Y-mAbs Therapeutics (YMAB) stock drops as Bank of America downgrades the company citing challenges for its only approved drug ...

Bicara Therapeutics shows potential to reshape cancer care with ficerafusp alfa and robust funding post-IPO. Find out why ...

Share prices across the world have been pummeled in recent days by economic doubts raised by tough trade talk from the Trump administration. And while short-term stock volatility is not always tied to ...

Over a shorter period of one year, the company's stock performance has outpaced both the broader market and the US Interactive Media and Services industry. The share price, currently at US$510.45 ...

Nasdaq Composite closed 335.35 points, or 2.15%, lower at 15,267.91. Tesla share price declined 4.90%, Nvidia stock price fell 1.37%, Advanced Micro Devices shares plunged 6.49%, while Intel stock ...

Wrecking the capital base of America will make nothing great again, but there still appears to be a level of denial about the consequences that has yet to be reflected in stock prices and indices.

The retired construction worker from Los Angeles said prices were already high ... When he spots a sale, he tries to stock up on the item when he can, but there are limits. He can fit only ...

The Canadian stock plays a critical role in the global energy supply chain. It provides the essential fuel for nuclear power plants operating in numerous countries around the world. Right now, the ...

But for investors, the big question remains: what does the future hold for EVgo’s stock price? This article will provide a detailed prediction for EVgo's stock price in 2025, 2026 and 2030 based ...